Ryvex is an authorized distributor of Hardy Diagnostics, a company that manufactures culture media, and rapid identification kits for microbiological testing in clinical, research, and industrial laboratories.
-
-
-
Specialty ID panels provide same-day identification of yeast, Haemophilus/Neisseria, and anaerobic bacteria. The technology tests for the presence of pre-formed enzymes used by the organism to metabolize various substrates.
-
A definitive identification (ID) in as little as 2.5 hours coupled with your hospital antibiogram provides rapid empiric therapy guidance. A good choice for common, high volume, gram-negative organisms – MicroScan Rapid panels achieve same day turnaround time for routine isolates.
-
-
Healthcare professionals are faced with a variety of significant fastidious pathogens where resistance to an extensive number of antibiotics is rapidly on the rise. This can lead to complications ranging from pediatric ear infections to life-threatening conditions such as meningitis or sepsis. For appropriate antimicrobial therapy, accurate minimum inhibitory concentration (MIC) testing should be assessed for all significant isolates.
-
- Detects the presence of viable Mycobacterium tuberculosis
- Performs susceptibility testing simultaneously and within the same procedure.
- Detects resistance to both isoniazid and rifampicin; the two most commonly used drugs for therapy.
- Uses liquid culture for accelerated growth.
- Utilizes the TB cording phenomenon for identification, which is easily viewed with an inverted microscope.
- Detects susceptible, mono-resistant, and multi-drug resistant (MDR) TB usually within a 5 to 10 day incubation period.
- Can be used to monitor patients on therapy. Detects only living organisms.
- Cost effective and labor saving
- Ready-to-use antibiotics available in an easy-to-dissolve tablet. No measuring, weighing, or mixing needed.
- All vials and reagents are color coded to simplify and error-proof the procedure.
- Unique protective flexible silicone sealing lid for increased safety. Tray remains permanently sealed throughout the entire incubation and examination procedure. Safety lid can be easily pierced with a needle/syringe if sub-culturing or rapid specification is necessary.
-
The WalkAway plus System delivers gold-standard accuracy for microorganism identification and susceptibility testing. This system delivers accurate emerging resistance detection for the toughest pathogens, including VISA, VRSA, and MRSA.
-
As the foundation of our identification and antibiotic susceptibility testing (ID/AST) products, Conventional panels deliver accuracy, choice, and flexibility. With the fewest FDA limitations of leading automated ID/AST systems, use of conventional panels reduces supplemental testing costs and reporting delays associated with rapid only systems.
- Direct minimum inhibitory concentration (MIC) susceptibility methodology helps ensure detection of emerging and low-level resistance, while combo ID/AST formats provide creative workflow solutions.
- Our exclusive, PROMPT™ inoculation method with 4-hour stability reduces inoculum preparation time by over 40% when compared to turbidity methods.
-
The autoSCAN-4 System processes panels in seconds, simplifying identification and antibiotic susceptibility testing (ID/AST) while standardizing results. Over 30 years of exceptional instrument reliability and our conventional panel technology – with the fewest FDA limitations in automated ID/AST – make the autoSCAN-4 an excellent supplemental system for difficult organisms or as a primary instrument for low-volume usage.
-
-
-
-
Organisms possessing Extended-Spectrum Beta-Lactamases (ES?L) may be clinically resistant to therapy with penicillins, cephalosporins, and aztreonam, despite apparent in vitro susceptibility to some of these agents. The incidence of these strains is on the rise and is a significant health concern in some regions. Because of this, the screening and confirmation of ES?L-producing strains is recommended by all major national guidelines.
